Brilanestrant

SI-5412

Brilanestrant, >98% (HPLC)

CAS No. : [1365888-06-7]

MDL No. : MFCD28902190

Synonyms : ARN-810; GDC-0810

IUPAC Name : (E)-3-(4-((E)-2-(2-Chloro-4-fluorophenyl)-1-(1H-indazol-5-yl)but-1-en-1-yl)phenyl)acrylic acid

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
10MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
25MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
50MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
100MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
250MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
500MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
1G	Request A Quote		Back Order	Estimated to ship on 04 October 2026

Applications : Brilanestrant is an orally bioavailable selective estrogen receptor degrader (SERD) with IC50 of 0.7 nM. Brilanestrant is under development for the treatment of locally advanced or metastatic estrogen receptor (ER)-positive breast cancer.

References : Lai A. et al.: J. Med Chem., 58(12), 4888-4904, 2015; Joseph J. D. et al.: Elife. 5. pii: e15828, 2016.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.